Table 1.
Baseline characteristics and stimulation parameters in the endometriosis and control groups. Values are shown as n (%), percentage (%) or mean ± SD.
| Variable | Endometriosis | Control | p Value |
|---|---|---|---|
| Group (n = 155) | Group (n = 969) | ||
| Duration of infertility (months) | 51.8 ± 29.3 | 56.8 ± 32.4 | 0.09 |
| Cycle rank | 2.0 ± 1.0 | 1.9 ± 1.1 | 0.2 |
| Age (years) | 32.1 ± 3.5 | 32.6 ± 4.5 | 0.2 |
| Body mass index (kg/m2) | 23.4 ± 4.3 | 24.6 ± 5.3 | 0.03 * |
| Tobacco use (%) | 34.3 | 35.9 | 0.9 |
| AMH (ng/mL) | 2.7 ± 2.3 | 3.9 ± 3.9 | 0.0002 * |
| Antral Follicular Count | 16 ± 10 | 20 ± 11 | <0.0001 * |
| Basal FSH (IU/L) | 7.5 ± 2.8 | 7.0 ± 2.5 | 0.1 |
| Total FSH administered (IU) | 2819 ± 1109 | 2342 ± 986 | <0.0001 * |
| Stimulation Protocol | |||
| Antagonist (%) | 58.7 | 88.5 | <0.0001 * |
| Agonist (%) | 39.4 | 9.9 | |
| Natural (%) | 1.9 | 1.5 | |
| Gonadotropin type | |||
| FSH (%) | 77.3 | 79.4 | 0.5 |
| FSH+LH (%) | 22.7 | 20.6 | |
| Total motile sperm count | 56.3 ± 80.4 | 18.6 ± 41.8 | <0.0001 * |
* significant.